항암화학요법과 한방치료를 병행하여 전환수술이 가능하게 호전된 진행성 위암 환자 1례

• Published in: 대한한방내과학회지 Vol. 41; no. 5; pp. 911 - 925
• Main Authors: 장권준, 고은비, 황우석, 김관일, 이범준, 정희재, 신광순, Jang, Kwon-jun, Ko, Eun-bi, Hwang, Woo-seok, Kim, Kwan-il, Lee, Beom-joon, Jung, Hee-jae, Shin, Kwang-soon
• Format: Journal Article
• Language: Korean
• Published: 대한한방내과학회 01.10.2020
• Subjects: 한의학; Korean medicine; advanced gastric cancer; Xeloda/Cisplatin; peritoneal metastasis; conversion surgery
• ISSN: 1226-9174
• DOI: 10.22246/jikm.2020.41.5.911

Objectives: The purpose of this study was to report a case of a patient with advanced gastric cancer with peritoneal metastasis treated with chemotherapy and Korean medicine Methods: A patient with advanced gastric cancer with peritoneal metastasis was treated with Xeloda/cisplatin since April 2019. The cycle was repeated every three weeks for a total of 11 times. At the same time, the patient was treated with Korean medicine. The tumor size was measured by computed tomography (CT) and esophagogastroduodenoscopy (EGD). Adverse events were evaluated by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0. Results: After treatment with Xeloda/cisplatin and Korean medicine for nine months, the extent of the proximal portion of the primary tumor and the size and number of multiple nodules around the stomach decreased and the cancer cells with peritoneal metastasis disappeared. The symptoms of discomfort and physical activity were gradually improved. As a result, the patient underwent conversion surgery. Conclusions: This case study suggests that the combination of chemotherapy and Korean medicine may contribute to the reduction in tumor size as well as the improvement in the quality of life.